Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-09-26
1993-08-10
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Lymphokine
435 4, 435 3, 435 29, 435269, 435 88, 514 2, 514 1, A61K 3900, C12Q 100, C12Q 300, C07K 300
Patent
active
052346854
ABSTRACT:
There is disclosed a method of determining the presence of incompatibility-reaction-causing substances in blood products. There is also disclosed a method of inactivating incompatibility-reaction-causing substances in blood products to be applied therapeutically and prophylactically. For this purpose, a fraction obtained from human or animal blood is treated with pancreas enzymes bound to water insoluble carrier material and, optionally, the fraction is subjected to further fractionation and concentration.
REFERENCES:
patent: 4276283 (1981-06-01), Eibl et al.
patent: 4371612 (1983-02-01), Matsumoto et al.
Workshop on Subchronic Toxicity Testing (1980) Proceedings of the Workshop EPA-5601/11-80-028.
Ed Page et al, Springfield Va.: National Technical Information Series. As referenced in Lu (1985) Basic Toxicology. Hemisphere Inc, Washington. pp. 99-112.
"Proceedings of the Workshop on Subchronic Toxicity Testing", Denver Colorado, May 20-24, 1979.
Eibl Johann
Linnau Yendra
Schwarz Otto
"Immuno" Aktiengesellschaft fur chemisch-medizinische Produkte
Nucker Christine M.
Preston D. R.
LandOfFree
Method of determining incompatibility-reaction-causing substance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining incompatibility-reaction-causing substance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining incompatibility-reaction-causing substance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1723655